Silverarc Capital Management’s Aclaris Therapeutics ACRS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Hold	0	–	–	–	69
2023 Q3	–	Sell	-219,229	Closed	-$1.87M	–	81
2023 Q2	$2.27M	Sell	219,229 -871	-0.4%	-$7.88K	0.77%	42
2023 Q1	$1.78M	Sell	220,100 -132,093	-38%	-$1.68M	0.8%	46
2022 Q4	$5.55M	Sell	352,193 -191,583	-35%	-$3.08M	1.91%	23
2022 Q3	$8.56M	Buy	543,776 +4,231	+0.8%	+$66.7K	3.63%	11
2022 Q2	$7.53M	Buy	539,545 +264,212	+96%	+$3.7M	3.53%	13
2022 Q1	$4.75K	Sell	275,333 -10,893	-4%	-$149K	2.25%	12
2021 Q4	$4.16M	Buy	286,226 +112,899	+65%	+$1.71M	1.87%	19
2021 Q3	$3.12M	Sell	173,327 -15,392	-8%	-$247K	1.81%	20
2021 Q2	$3.31K	Sell	188,719 -148,018	-44%	-$3.36M	1.62%	21
2021 Q1	$8.49M	Buy	+336,737	New	+$6.59M	4.75%	1